ELND005
4 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
4
Ongoing
0
Recruiting
0
Completed
4
Sites
136
Countries
4
Endpoints
36
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 36 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 20 of 36 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
8
6
2
2
2
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
4 of 4
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| NCT01735630Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease | ELND005 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 70 | May 2015 | - | results |
| NCT00568776ELND005 in Patients With Mild to Moderate Alzheimer's Disease | ELND005 Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 62 | May 2010 | - | results |
| NCT00934050ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease | ELND005 Alzheimer’s disease | - | Ph 2 | Completed | 38 | Jun 2011 | - | results |
| DS201A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia | ELND005 Mixed / unspecified dementia | Age 18-45 | Ph 2 | Completed | 3 | Jun 2014 | 1 | results |
Showing 1-4 of 4 trials